MétaCan
Menu
Back to cohort
Record W4416438981 · doi:10.1111/liv.70423

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the <scp>GALA</scp> Study Group

2025· article· en· W4416438981 on OpenAlexafffund
Carla Fiorella Murillo Perez, Shannon M. Vandriel, Emmanuel Gonzalès, Jian‐She Wang, Liting Li, Huiyu She, Irena Jankowska, Piotr Czubkowski, Dorota Gliwicz‐Miedzińska, Emmanuel Jacquemin, Jérôme Bouligand, Lorenzo D’Antiga, Emanuele Nicastro, Björn Fischler, Henrik Arnell, Susan Siew, Michael Stormon, Kathleen M. Loomes, David A. Piccoli, Elizabeth B. Rand, James E. Squires, Saul J. Karpen, René Romero, Mureo Kasahara, Zerrin Önal, Étienne Sokal, Tanguy Demaret, Sabina Więcek, Florence Lacaille, Dominique Debray, Winita Hardikar, Sahana Shankar, Pamela L. Valentino, Shikha S. Sundaram, Noelle H. Ebel, Jeffrey A. Feinstein, Orith Waisbourd‐Zinman, Henry C. Lin, Nathalie Rock, Henkjan J. Verkade, M. Kyle Jensen, Catalina Jaramillo, Kyung Mo Kim, Seak Hee Oh, Jernej Brecemiclj, Seema Alam, Giuseppe Indolfi, Niviann Blondet, Rima Fawaz, Silvia Nastasio, Pier Luigi Calvo, Gabriella Nebbia, Çiğdem Arıkan, Catherine Larson‐Nath, Andréanne N. Zizzo, Thomas Damgaard Sandahl, Christos Tzivinikos, Nehal El‐Koofy, Mohamed A. Elmonem, Amal Aqul, Wikrom Karnsakul, Pınar Bulut, Nanda Kerkar, Victorien M. Wolters, Amin J. Roberts, Helen Evans, Maria Camila Sanchez, Maria Lorena Cavalieri, Déirdre Kelly, Jane Hartley, Way Seah Lee, Christina Hajinicolaou, Chatmanee Lertudomphonwanit, Ryan T. Fischer, Rubén E. Quirós‐Tejeira, Cristina Targa Ferreira, Elisa de Carvalho, John Eshun, Aglaia Zellos, Antal Dezsőfi, Raquel Borges Pinto, Kathleen B. Schwarz, Maria Rogalidou, Jennifer García, María Legarda Tamara, Marisa Beretta, Quais Mujawar, Ermelinda Santos Silva, Cristina Molera Busoms, Eberhard Lurz, Cristina Gonçalves, Carolina Jiménez‐Rivera, Jesús M. Bañales, Richard J. Thompson, Bettina E. Hansen, Binita M. Kamath

Bibliographic record

VenueLiver International · 2025
Typearticle
Languageen
FieldMedicine
TopicPediatric Hepatobiliary Diseases and Treatments
Canadian institutionsInstitute of Health Services and Policy ResearchChildren's Hospital of Eastern OntarioUniversity of ManitobaWestern UniversityHospital for Sick ChildrenToronto General HospitalUniversity Health NetworkUniversity of TorontoChildren's Hospital of Western OntarioLondon Health Sciences Centre
FundersCliniques Universitaires Saint-LucUniversity of Colorado School of Medicine, Anschutz Medical CampusSchool of Medicine, Emory UniversityUniwersytet Śląski w KatowicachIpsenŚląski Uniwersytet Medyczny w KatowicachAssistance publique-Hôpitaux de ParisUniversité Paris-SaclayUniversité de GenèveUniversitair Medisch Centrum GroningenHospital for Sick ChildrenSchool of Medicine, Stanford UniversityFudan UniversityPerelman School of Medicine, University of PennsylvaniaUniversity of UlsanKarolinska InstitutetInstitut National de la Santé et de la Recherche MédicaleUniversity of WashingtonAudentes TherapeuticsHorizon PharmaceuticalsIpsen BiopharmaceuticalsDanoneChildren's Healthcare of AtlantaUniversity of PennsylvaniaSeattle Children's Research InstituteVirginia Commonwealth UniversityNational Natural Science Foundation of ChinaAlagille Syndrome AllianceUniversity of PittsburghAlexion PharmaceuticalsUniversity of TorontoEmory UniversityNational Center for Child Health and DevelopmentChildren's Hospital of Philadelphia
KeywordsAlagille syndromeBile acidCholestasisLiver diseaseDisease

Abstract

fetched live from OpenAlex

BACKGROUND AND AIM: Alagille syndrome (ALGS) is a rare disorder characterised by cholestasis and extrahepatic manifestations. Given the current era of ileal bile acid transporter (IBAT) inhibitor therapies that reduce serum bile acid (SBA) levels, we evaluated whether SBA predicts liver disease outcomes in ALGS. METHODS: Patients were ascertained from the Global ALagille Alliance (GALA) cohort. A prognostic threshold of SBA 102 μmol/L was assessed as a time-dependent covariate in Cox regression analyses for native liver survival (NLS) and event-free survival (EFS), while adjusting for total bilirubin (TB) levels. RESULTS: 570 GALA patients were included (348 [61%] male). There was a moderate positive correlation between SBA and TB (Pearson correlation = 0.47, p < 0.001). SBA below 102 μmol/L was a significant predictor of outcomes (NLS: HR = 3.78, 95% CI 2.39-5.99, p < 0.001; EFS: HR = 3.44, 95% CI 2.35-5.04, p < 0.001). SBA remained a significant predictor for improved EFS after adjusting for TB clearance at 1 year (TB < 2 mg/dL; HR = 2.00, 95% CI 1.10-3.65, p = 0.02). Median SBA in the first year of life above 102 μmol/L, predicted lower NLS (67.2% vs. 83.5% at 7 years p = 0.05) and EFS (63.4% vs. 80.9% at 7 years, p = 0.02). CONCLUSION: Lower SBA in children with ALGS liver disease predicts improved NLS and EFS. SBA is also associated with NLS in children with ALGS who clear their bilirubin, that is, those with anicteric cholestasis. Although the patients studied here did not receive IBAT inhibition, these data suggest that lowering SBA may improve important clinical outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.009
Threshold uncertainty score0.577

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.244
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueLiver InternationalSame topicPediatric Hepatobiliary Diseases and TreatmentsFrench-language works237,207